Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Surgical Stress Index (SSI) During Sevoflurane/Remifentanil Anesthesia
This study has been completed.
Sponsored by: University of Schleswig-Holstein
Information provided by: University of Schleswig-Holstein
ClinicalTrials.gov Identifier: NCT00791791
  Purpose

The aim of the present prospective randomized study was to challenge the ability of SSI to detect painful stimulation during sevoflurane - remifentanil anesthesia.


Condition Intervention
Analgesia
Procedure: standardized pain stimulus

MedlinePlus related topics: Anesthesia
Drug Information available for: Sevoflurane Remifentanil Remifentanil hydrochloride
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized

Further study details as provided by University of Schleswig-Holstein:

Primary Outcome Measures:
  • SSI, compared to standard monitoring variables [ Time Frame: during anesthesia ] [ Designated as safety issue: No ]

Enrollment: 24
Study Start Date: August 2008
Study Completion Date: November 2008
Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1
increasing remifentanil administration
Procedure: standardized pain stimulus
a tetanic stimulus (30s, 50 Hz, 60mA) applied as standardized pain stimulus
2
decreasing remifentanil concentration
Procedure: standardized pain stimulus
a tetanic stimulus (30s, 50 Hz, 60mA) applied as standardized pain stimulus

Detailed Description:

General anesthesia can be considered as a combination of hypnosis, antinociception and immobility. Whereas monitoring of depth of hypnosis, and muscle relaxation can be regarded as accepted, determination of the nociception is based on clinical signs like somatic or autonomic responses.

Recently, the multivariate surgical stress index (SSI)has been demonstrated to correlate with surgical stress intensity. Thus, SSI might be a useful variable to adjust analgesic drug administration in individual patients.

We want to investigate whether SSI is able to indicate nociception following standardized noxious stimulation during balanced sevoflurane - remifentanil anesthesia.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age between 18 and 65 years
  • ASA physical status 1-2
  • elective surgery in general anesthesia of 1 to 2 hours
  • written informed consent

Exclusion Criteria:

  • pregnancy
  • history of cardiac arrhythmia
  • presence of any neuromuscular or neurological disease
  • use of CNS-active medication or abuse of alcohol or illicit drugs
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00791791

Locations
Germany, SH
Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel
Kiel, SH, Germany, D-24105
Sponsors and Collaborators
University of Schleswig-Holstein
Investigators
Principal Investigator: Matthias Gruenewald, MD Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel
Study Chair: Berthold Bein, MD, DEAA Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel
  More Information

Publications:
Responsible Party: University Hospital Schleswig Holstein ( PD Dr. Berthold Bein DEAA )
Study ID Numbers: SSI-134-1
Study First Received: November 14, 2008
Last Updated: November 14, 2008
ClinicalTrials.gov Identifier: NCT00791791  
Health Authority: Germany: Ethics Commission

Keywords provided by University of Schleswig-Holstein:
Anesthesia General
Anesthetics Inhalation
Stress measurement
Surgical Stress
Diagnostic Techniques and Procedures

Study placed in the following topic categories:
Remifentanil
Stress
Sevoflurane

ClinicalTrials.gov processed this record on January 16, 2009